Universty of Capecoast
Cape Coast, Ghana
NCT Number: NCT02505516
patients om metformin from diabetic clinic were checked for bladder cancer
Looking for future studies?
Notify Me25 year–86 year
All sexes
Interventional
Early Phase 1
Cape Coast, Ghana
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: glucophage
Time frame: 6 months
UFUOMA MILLER FAKPOR
Other
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01637935
Bladder Cancer, Diabetes
View Trial DetailsNCT01236053
Adenocarcinoma, Anal Cancer
View Trial DetailsNCT06357416
Alcohol-Related Disorders, Alcoholism
London, United Kingdom
View Trial DetailsNCT02716623
Bladder Cancer, Diabetes Mellitus
Kansas City, Kansas, United States
View Trial Details